Kincellis Advanced Therapies Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Merger of Eq.

  • Financing Rounds
  • 1

  • Investments
  • 2

Kincellis Advanced Therapies General Information

Description

Provider of cell therapy contract development and manufacturing services intended to advance innovative medical treatments. The company's technology utilizes modular cleanrooms, integrated quality control laboratories, and advanced closed processing systems, providing biopharmaceutical firms with process development, analytical services, and cgmp manufacturing to accelerate the production of car-t and gene-modified cell therapies for commercial readiness.

Contact Information

Formerly Known As
Cellipont Bioservices, Kincell Bio
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • United States
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kincellis Advanced Therapies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kincellis Advanced Therapies‘s full profile, request access.

Request a free trial

Kincellis Advanced Therapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kincellis Advanced Therapies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kincellis Advanced Therapies‘s full profile, request access.

Request a free trial

Kincellis Advanced Therapies Acquisitions (2)

Kincellis Advanced Therapies’s most recent deal was a Merger/Acquisition with Cellipont Bioservices. The deal was made on 17-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cellipont Bioservices 17-Sep-2026 Merger/Acquisition BPO/Outsource Services
Kincell Bio 17-Sep-2026 Merger/Acquisition Biotechnology
To view Kincellis Advanced Therapies’s complete acquisitions history, request access »

Kincellis Advanced Therapies FAQs

  • When was Kincellis Advanced Therapies founded?

    Kincellis Advanced Therapies was founded in 2026.

  • Where is Kincellis Advanced Therapies headquartered?

    Kincellis Advanced Therapies is headquartered in .

  • What is the size of Kincellis Advanced Therapies?

    Kincellis Advanced Therapies has 200 total employees.

  • What industry is Kincellis Advanced Therapies in?

    Kincellis Advanced Therapies’s primary industry is Biotechnology.

  • Is Kincellis Advanced Therapies a private or public company?

    Kincellis Advanced Therapies is a Private company.

  • What is Kincellis Advanced Therapies’s current revenue?

    The current revenue for Kincellis Advanced Therapies is .

  • Who are Kincellis Advanced Therapies’s investors?

    Great Point Partners, HealthQuest Capital, Kineticos Life Sciences Management, NewSpring Capital, and OrbiMed have invested in Kincellis Advanced Therapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process